European Parliament does not call for premarket review of IVDs

04/18/2013 | Clinica (subscription required)

In vitro diagnostic products would not be subject to centralized or decentralized premarket approval under a draft report released by the European Parliament on IVD regulation in Europe. Rather, the report calls for improving the system for notified bodies and reinforcing the market oversight and vigilance program, among other recommendations.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY